Eagle Pharmaceuticals (NASDAQ:EGRX) reported its Q2 earnings results on Tuesday, August 9, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

Earnings

Eagle Pharmaceuticals posted an EPS of $1.56.

Revenue was up $26.01 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.16 which was followed by a 3.91% increase in the share price the next day.

Here's a look at Eagle Pharmaceuticals's past performance:

To track all earnings releases for Eagle Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.